Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans

NCT03077360 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03077360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03077360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2017
Completion date
November 19, 2020
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, obesity, pre-diabetes